Allurion Technologies, Inc. (ALUR) has disclosed a new risk, in the Regulation category.
Allurion Technologies, Inc. faces substantial business risk if it fails to navigate the complex landscape of health care regulations. Although the company does not directly bill Medicare or Medicaid, it is still subject to a myriad of fraud and abuse laws, as well as patients’ rights regulations, which could lead to severe penalties and operational disruptions if violated. The company’s financial condition could be significantly impacted by the costs of legal defense, penalties, and the potential loss of certifications that authorize product distribution. Furthermore, non-compliance could tarnish Allurion’s reputation and restrict its revenue streams, highlighting the critical nature of maintaining a robust and compliant Quality System.
The average ALUR stock price target is $5.00, implying 184.09% upside potential.
To learn more about Allurion Technologies, Inc.’s risk factors, click here.
